Healthcare provider profile · identity verified

Darlene G Esken, APN

Nurse Practitioner · MORTON, IL · NPI 1710346309

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	245	96
Lisinopril	Lisinopril	186	60
Levothyroxine Sodium	Levothyroxine Sodium	151	48
Amlodipine Besylate	Amlodipine Besylate	131	41
Gabapentin	Gabapentin	119	44
Metoprolol Succinate	Metoprolol Succinate	97	34
Losartan Potassium	Losartan Potassium	90	32
Pravastatin Sodium	Pravastatin Sodium	77	25
Omeprazole	Omeprazole	74	34
Simvastatin	Simvastatin	72	25
Sertraline Hcl	Sertraline Hcl	67	22
Hydrochlorothiazide	Hydrochlorothiazide	62	22
Alendronate Sodium	Alendronate Sodium	58	21
Metformin Hcl	Metformin Hcl	54	22
Montelukast Sodium	Montelukast Sodium	54	20
Tamsulosin Hcl	Tamsulosin Hcl	53	18
Rosuvastatin Calcium	Rosuvastatin Calcium	52	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	20
Escitalopram Oxalate	Escitalopram Oxalate	50	20
Albuterol Sulfate Hfa	Albuterol Sulfate	43	18
Metoprolol Tartrate	Metoprolol Tartrate	39	16
Furosemide	Furosemide	38	14
Tramadol Hcl	Tramadol Hcl	38	23
Buspirone Hcl	Buspirone Hcl	36	13
Prednisone	Prednisone	36	32
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	33	12
Irbesartan	Irbesartan	32	suppressed
Januvia	Sitagliptin Phosphate	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	11
Lorazepam	Lorazepam	31	15
Metformin Hcl Er	Metformin Hcl	31	13
Trazodone Hcl	Trazodone Hcl	31	15
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	11
Atenolol	Atenolol	27	suppressed
Cephalexin	Cephalexin	27	18
Glipizide Er	Glipizide	27	suppressed
Paroxetine Hcl	Paroxetine Hcl	27	11
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Fluticasone Propionate	Fluticasone Propionate	26	suppressed
Allopurinol	Allopurinol	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	11
Meloxicam	Meloxicam	23	11
Ozempic	Semaglutide	23	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Famotidine	Famotidine	21	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	21	13
Celecoxib	Celecoxib	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	19	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Baclofen	Baclofen	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Naproxen	Naproxen	16	13
Desmopressin Acetate	Desmopressin Acetate	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Finasteride	Finasteride	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Eliquis	Apixaban	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error